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INTRODUCTION
Familial glucocorticoid deficiency (FGD), also known as
isolated glucocorticoid deficiency or hereditary unrespon-
siveness to ACTH, is an autosomal recessive disorder (1-4).
Patients suffer from recurrent hypoglycemia, convulsions,
hyperpigmentation, recurrent infections and failure to thrive
(3). Investigation shows severe cortisol deficiency despite a
high plasma ACTH levels, which leading to increased skin
pigmentation as a result of activation of α -melanocyte stim-
ulating hormone receptors (melanocortin-1 receptors) on
cutaneous melanocytes (3, 4). There is no mineralocorticoid
deficiency and the renin-angiotensin system is not affected.
The molecular basis of this condition was first described in
1992 (5), and approximately 20 different ACTH receptor
(MC2R) mutations have been reported in individuals or fam-
ilies with FGD (4, 6). Here, we report a boy with clinical and
biochemical features of FGD who is homozygous for a muta-
tion (D103N) in the MC2R gene. This is the first Korean
report of FGD associated with a mutation of the MC2R gene.
CASE REPORT
The patient was born to nonconsanguineous Korean par-
ents at 40 weeks of gestation by Caesarean section for induc-
tion failure, with a birth weight of 3.7 kg. He was the only
baby and there was no neonatal or infant death on family his-
tory. At first week after birth, he showed jaundice and treated
with phototherapy for 3 days at local hospital. At 2 months
of age, the patient was referred to our hospital for generalized
hyperpigmentation. His weight was 7.1 kg (75th percentile)
and length was 62.7 cm (75th percentile). Physical exami-
nation showed diffuse pigmentation of body including, oral
mucosa, gum, hands, nails and scrotum. The external geni-
talia showed normal development. Routine laboratory tests
including CBC, Na, K, Cl, Bun, Cr and glucose were nor-
mal, but AST (139 IU/L, normal range 15-55 IU/L), ALT
(60 IU/L, normal range 5-45 IU/L), total bilirubin (6.7 mg/
dL, normal range 0.2-1.2 mg/dL) and direct bilirublin (2.6
mg/dL, normal range 0-0.4 mg/dL) levels were elevated. A
99mTc-DISIDA (Diisopropyl Iminodiacetic Acid) hepato-
biliary scan was done and revealed neonatal hepatitis. Endo-
crinological evaluation showed very low serum cortisol level
(0.3 μ g/dL, normal range 5-23 μ g/dL, 8:00 A.M.), with very
high plasma ACTH level (18,000 pg/mL, normal range 10-
60 pg/mL, 8:00 A.M.) at 09:00 hours. In response to a rapid
ACTH stimulation test (15 μ g/kg bolus i.v.), his cortisol rose
minimally from 1.0 to 2.6 μ g/dL. Plasma renin activity, aldos-
terone, 17-hydroxyprogesterone and very long-chain fatty
acids were all normal. Abdominal ultrasonography showed
normal adrenal glands. On the basis of the above findings, he
was diagnosed with FGD, and was treated with oral hydro-
cortisone (15 mg/m2/day). Six months later, hyperpigmenta-
tion was markedly reduced, and the plasma ACTH level was
reduced to 195.7 pg/mL. The patient has done well, but the
979
Chan Jong Kim
1, Young Jong Woo
1,
Gu Hwan Kim
2, and Han Wook Yoo
2
Department of Pediatrics
1, Chonnam National
University Medical School, Gwangju; Department of
Pediatrics
2, Asan Medical Center, University of Ulsan
College of Medicine, Seoul, Korea
Address for correspondence
Chan Jong Kim, M.D.
Department of Pediatrics, Chonnam National University
Medical School, 8 Hak-dong, Dong-gu, Gwangju
501-757, Korea
Tel : +82.62-220-6645, Fax : +82.62-222-6103
E-mail : cjkim@jnu.ac.kr
J Korean Med Sci 2009; 24: 979-81
ISSN 1011-8934
DOI: 10.3346/jkms.2009.24.5.979
Copyright � The Korean Academy
of Medical Sciences
Familial Glucocorticoid Deficiency with a Point Mutation in the ACTH
Receptor: A Case Report
Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder char-
acterized by severe glucocorticoid deficiency associated with failure of adrenal res-
ponsiveness to ACTH but no mineralocorticoid deficiency. We report a 2 month-old
boy of nonconsanguineous parents, presented with hyperpigmentation. Physical
examination showed diffuse dark skin of body including, oral mucosa, gum, hands,
nails and scrotum. Laboratory evaluation revealed low serum cortisol (0.3 μ g/dL),
with very high plasma ACTH level (18,000 pg/mL), and serum cortisol level did not
increase after ACTH stimulation test. Serum sodium, potassium, plasma renin activi-
ty, aldosterone and 17-hydroxyprogesterone were normal. Sequence analysis of
the ACTH receptor (MC2R) gene showed a homozygous mutation of D103N. Diag-
nosis of FGD was made and treatment started with oral hydrocortisone.
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Accepted : 28 April 2008plasma ACTH level has been variable (range of 190 to 3,440
pg/mL), throughout the 2 yr of hydrocortisone replacement
therapy (15-20 mg/m2/day).
Mutational analysis of the MC2R gene
Genomic DNA was isolated from peripheral blood using
PUREGENE DNA isolation kit (Gentra, Minneapolis, MN,
U.S.A.). The entire coding sequence of the MC2R gene was
amplified by PCR with 4 sets of primers (Table 1). The ampli-
fications were performed in 30 cycles, each cycle consisting
of denaturation at 95℃ for 30 sec, annealing at 55℃ for 30
sec, and extension at 72℃ for 45 sec. PCR was carried out
in reaction volumes of 20 μ L, containing 100 ng of genom-
ic DNA template, 1 μ M each primer, 200 μ M each dNTPs,
1.5 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl (pH 8.3),
and one unit of Taq polymerase (Promega, Madison, WI,
U.S.A.). After amplification, PCR mixtures were run on 1.2%
agarose gel in the presence of ethidium bromide. PCR prod-
ucts were purified and subjected to direct sequencing from
both directions on an ABI 3130xl Genetic analyzer (Applied
Biosystems, Foster city, CA, U.S.A.). We identified a point
mutation (D103N) in the MC2R gene. The patient was ho-
mozygous (Fig. 1), and both asymptomatic parents were he-
terozygous for this mutation.
DISCUSSION
The diagnosis of FGD is based on clinical findings, low
serum cortisol in the presence of excessively elevated ACTH,
proof of normal aldosteorne production, and the exclusion
of other causes of adrenal failure (3, 4). The most common
initial presenting sign is severe hyperpigmentation of the
skin and mucosa membrane. Other presenting features in-
clude recurrent hypoglycemia, feeding problems, regurgita-
tion, failure to thrive and severe infections (3, 4). In newborns,
symptoms of hypoglycemia can be subtle, so a high index of
suspicion is needed (3). Often these patients are significantly
jaundiced and may require phototherapy (7). In some cases
this appears to result from a transient hepatitis (8). Our case
also showed jaundice and transient hepatitis. Although this
disease is easily treatable when recognized, if left untreated
it may be fatal or lead to severe mental disability as a result
of recurrent hypoglycemia secondary to glucocorticoid insuf-
ficiency (3, 4). The exact incidence of FGD is not known. It
is a rare disease, and only isolated case reports are document-
ed. Three Korean patients of FGD were reported, but the
gene studies were not done (9).
The ACTH receptor is a member of the melanocortin recep-
tor family, consisting of five closely related genes that encode
seven-transmembrane G protein-coupled receptors (5). All
five of these receptors can bind ACTH to some extent, but
MC2R binds ACTH at the highest affinity, is expressed almost
exclusively in the adrenal cortex, and hence is the physiolog-
ical ACTH receptor (3). After the MC2R gene was cloned
(10), approximately 20 different MC2R mutations have been
reported in patients with FGD (6, 7, 10). MC2R is a 297-
amino acid protein, encoded by a gene on chromosome 18p11.2
(5). Our patient had a homozygous mutation (D103N) of
MC2R gene, and it was previously reported (4). This mis-
sense mutation is in the first extracellular loop of the recep-
tor and may impair ACTH binding (4, 6, 11). However, the
etiology of FGD is heterogeneous, and not all patients with
FGD have been found to have MC2R gene mutations (4, 7).
Patients with FGD who have mutations in the MC2R gene
are said to have FGD type 1, and patients in whom no such
mutations are found have FGD type 2 (4). Recently, Metherall
et al. (12) identified mutations in a gene encoding the mela-
nocortin 2 receptor accessory protein (MRAP), which inter-
acts with MC2R and may have a role in the trafficking of
MC2R. They demonstrated that mutations in MRAP caus-
ed FGD in 19 of 104 kindreds with confirmed FGD and no
MC2R mutations (12). On current evidence, inactivating
mutations of MC2R gene account for about 25% of all FGD
cases, and mutations in MRAP gene account for about 20%
of FGD cases, implying that at least half of all FGD cases
result from other genes yet to be identified (4). So further
studies for identification of these genes will have implications
for the detailed understanding of FGD.
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1S, 2S, 3S and 4S are sense primiers, and 1A, 2A, 3A and 4A are anti-
sense primers. Primers were designed with primer3 cgi v.2.0 served from
Whitehead Institute (http://frodo.wi.mit.deu/cgi-bin/primer3/primer3_
www.cgi) using sequences from GenBank accession number of NT_
010859.14.
1S 5′ -AGAATCAATCAAGTTTTCCGT-3′
1A 5′ -AGATAGCCCATGTTTCTCAAT-3′
2S 5′ -AGAATAAGAATCTCCAGGCAC-3′
2A 5′ -ACATGATGGGAGAAGATCAC-3′
3S 5′ -GCTACATCACCATCTTCCAC-3′
3A 5′ -TGTCATCAAGAGGACATGAA-3′
4S 5′ -AGGAAGATCTCCACCCTCC-3′
4A 5′ -GCATTTGTTGGAATGTTACAC-3′
Table 1. Sequences of oligonucleotide primers
Fig. 1. Genetic analysis revealed a homozygous mutation in the
coding region of the MC2R gene, consisting of a guanine to ade-
nine transition at the first position of codon 103, resulting in sub-
stitution of aspartic acid for asparagine (D103N). 
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